94828-17-8

Basic information

• Product Name: (2'E,6'E,10'E,14'E,18'E,22'E,26'E,30'E,34'E,38'E)-1-(3',7',11',15',19',23',27',31',35',39'-decamethyltetraconta-2',6',10',14',18',22',26',30',34',38'-decaenyl)-6-methyl-2,3,4,5-tetramethoxybenzene
• Synonyms: (2'E,6'E,10'E,14'E,18'E,22'E,26'E,30'E,34'E,38'E)-1-(3',7',11',15',19',23',27',31',35',39'-decamethyltetraconta-2',6',10',14',18',22',26',30',34',38'-decaenyl)-6-methyl-2,3,4,5-tetramethoxybenzene
• CAS NO: 94828-17-8
• Molecular Weight: 893.431
• Mol File: 94828-17-8.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: (2'E,6'E,10'E,14'E,18'E,22'E,26'E,30'E,34'E,38'E)-1-(3',7',11',15',19',23',27',31',35',39'-decamethyltetraconta-2',6',10',14',18',22',26',30',34',38'-decaenyl)-6-methyl-2,3,4,5-tetramethoxybenzene(CAS DataBase Reference)
• NIST Chemistry Reference: (2'E,6'E,10'E,14'E,18'E,22'E,26'E,30'E,34'E,38'E)-1-(3',7',11',15',19',23',27',31',35',39'-decamethyltetraconta-2',6',10',14',18',22',26',30',34',38'-decaenyl)-6-methyl-2,3,4,5-tetramethoxybenzene(94828-17-8)
• EPA Substance Registry System: (2'E,6'E,10'E,14'E,18'E,22'E,26'E,30'E,34'E,38'E)-1-(3',7',11',15',19',23',27',31',35',39'-decamethyltetraconta-2',6',10',14',18',22',26',30',34',38'-decaenyl)-6-methyl-2,3,4,5-tetramethoxybenzene(94828-17-8)

Safety Data

• Hazardous Substances Data: 94828-17-8(Hazardous Substances Data)

Upstream product

• 13190-97-1 solanesol 
• 94828-31-6 methyl (E)-2-methyl-4-(2,3,4,5-tetramethoxy-6-methylphenyl)but-2-en-1-ol 
• 94828-11-2 1-((E)-4-Bromo-3-methyl-but-2-enyl)-2,3,4,5-tetramethoxy-6-methyl-benzene 
• 70854-64-7 solanesyl p-tolyl sulphone 
• 52610-77-2 solanesyl bromide 
• 618457-07-1 (2'E,6'E,10'E,14'E,18'E,22'E,26'E,30'E,34'E,38'E)-1-(3,7',11',15',19',23',27',31',35',39'-decamethyl-4'-phenylsulfonyltetraconta-2',6',10',14',18',22',26',30',34',38'-decaenyl)-6-methyl-2,3,4,5-tetramethoxybenzene 
• 114060-31-0 1-<(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-9,17,25,33-tetrakis(p-tolylsulfonyl)tetraconta-2,6,10,14,18,22,26,30,34,38-decaenyl>-2,3,4,5-tetramethoxy-6-methylbenzene 
• 94828-16-7 1-(5'-p-tosyl-all-trans-decaprenyl)-2-methyl-3,4,5,6-tetramethoxybenzene 
• 139137-97-6 2,2-Dimethyl-3-[(3E,7E,11E,15E,19E)-3,7,11,15,19-pentamethyl-21-(2,3,4,5-tetramethoxy-6-methyl-phenyl)-henicosa-3,7,11,15,19-pentaenyl]-oxirane 
• 118579-97-8 1-((2E,6E,10E,14E,18E)-3,7,11,15,19,23-Hexamethyl-tetracosa-2,6,10,14,18,22-hexaenyl)-2,3,4,5-tetramethoxy-6-methyl-benzene 
• 139137-96-5 diisopropyl <(4E)-1-isopropenyl-4-methyl-6-(2,3,4,5-tetramethoxy-6-methylphenyl)-4-hexenyl>phosphate 
• 85228-84-8 (E)-2,6-Dimethyl-8-(2,3,4,5-tetramethoxy-6-methyl-phenyl)-octa-1,6-dien-3-ol 
• 85228-79-1 1-<(2E)-6,7-epoxy-3,7-dimethyloct-2-enyl>-2,3,4,5-tetramethoxy-6-methylbenzene 
• 83036-57-1 (E)-1-(3,7-dimethylocta-2,6-dien-1-yl)-2,3,4,5-tetramethoxy-6-methylbenzene 

Downstream Products

• 303-98-0 ubidecarenone 
• 303-98-0 2-((2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-Decamethyl-tetraconta-2,6,10,14,18,22,26,30,34,38-decaenyl)-5,6-dimethoxy-3-methyl-[1,4]benzoquinone 

Relevant articles and documents

A process for the preparation of coenzyme Q10

A process for the preparation of the compound of formula II by removal of the phenylsulfone group from the compound of formula I characterized in that the phenylsulfone group is removed in the presence of PdCl2-1,2-diphenylphosphinoethane and LiHBEt3.

Highly S(N)2'-, (E)-, and antiselective alkylation of allylic phosphates. Facile synthesis of coenzyme Q10

Treatment of secondary allylic chlorides or allylic phosphates in tetrahydrofuran with prenyl Grignard reagent in the presence of CuCN · 2 LiCl gave geraniol or farnesol derivatives with high S(N)2' selectivity. Phosphate leaving groups were highly transstereoselective for the formation of (E,E)-farnesol derivatives. Furthermore, complete anti-S(N)2' selectivity was observed in the alkylation of optically active allylic phosphates. The present method appears to be an excellent carbon-carbon coupling reaction with high regio-, (E)-, and enantioselectivity. Coenzyme Q10 (ubiquinone 10) was efficiently synthesized using this methodology.

Synthetic Studies on Isoprenoidquinones. II. Syntheses of Ubiquinone-10, Phylloquinone, and Menaquinone-4 by a Chain-Extending Method Utilizing Terminally Functionalized Isoprenoidhydroquinones

Physiologically active polyisopreoidquinones, ubiquinone-10 (coenzyme Q10), phylloquinone (vitamin K1), and menaquinone-4 (vitamin K2(20)) were synthesized by a chain-extending method utilizing protected hydroquinones with the omega-hydroxyprenyl or omega-hydroxygeranyl side chain.Conditions for reductive desulfurization subsequent to allylic homologation was investigated. Keywords - polyisoprenoidquinone synthesis; ubiquinone-10; phylloquinone; menaquinone-4; chain-extending method; sulfone coupling; reductive desulfurization